Dr. Dingxiao Zhang (PhD.) is an Assistant Professor of Oncology in Roswell Park Cancer Institute (RPCI). Dr. Zhang graduated from Chungbuk National University with a Ph.D degree in Molecular Embryology in South Korea 2010. During his doctoral studies, he worked extensively on early embryo development and regulation of maternal gene expression, which led to 8 important publications in the field. After finishing Ph.D studies, he did a short post-doctoral training at the University of Cincinnati College of Medicine, studying the role of MED1 and ARGLU1 in breast cancer, with a first author J Biol Chem paper. He then joined MD Anderson Cancer Center (MDACC) as a postdoctoral fellow in February 2012. During his postdoctoral training at MDACC, he has published 10 papers. He was appointed to an Instructor position in MDACC 2015, and an Assistant Professor of Oncology in RPCI 2016. Currently, he is using genetic mouse models, cancer cell lines and xenografts, as well as human primary tumor samples to investigate the prostate development (epithelial biology) and prostate tumorigenesis and progression.

Stem cell and Cancer stem cells; Cancer cell heterogeneity; Prostate and Breast cancer; Epigenetics and Nuclear receptors.